Coronavirus restrictions were reimposed across much of Italy on Monday, while Ireland and the Netherlands became the latest countries to suspend AstraZeneca's Covid-19 shots over blood clot fears despite the firm and the WHO insisting there is no risk.
More than 350 million vaccine doses have been administered globally so far, and the AstraZeneca shot -- among the cheapest available -- is crucial to roll-outs in poorer parts of the world.
Despite immunisation programmes gathering pace, surges in infections remain a threat and Italian authorities reimposed restrictions on three-quarters of the country until April 6 to suppress an outbreak fuelled by the variant first detected in Britain.
Health Minister Roberto Speranza said Sunday the government hoped these strict measures and ongoing vaccinations would allow a relaxation of curbs later.
"Each dose of vaccine injected is a step in the direction of the way out of the crisis," he added.
Schools, restaurants, shops and museums will close, including in Rome and Milan, with residents told to stay home except for work, health or other essential reasons.
And while France was hoping to avoid another national lockdown, it was facing a hospital crisis with intensive care beds in the Paris region running out.
The coronavirus has killed more than 2.6 million people around the world, with much of humanity going through varying levels of Covid-19 restrictions.
People have been growing weary of the economically painful curbs, however.
The Netherlands -- under tight restrictions including an overnight curfew -- was set to begin three days of voting on Monday in a popularity test of the government's coronavirus policies.
Prime Minister Mark Rutte was set to win another term in office, but opposition to the restrictions was on display on the eve of the vote in The Hague Sunday as police used water cannon to clear an anti-government protest.
- AstraZeneca worries -
As they battle virus surges, health authorities in Italy and France have backed the Covid-19 vaccine developed by AstraZeneca and the University of Oxford, as several countries suspended use of the shot over fears it causes side effects such as blood clots.
Ireland and the Netherlands stopped giving out the shot on Sunday, joining Denmark, Norway and Bulgaria.
But the World Health Organization, Europe's medicines watchdog, AstraZeneca and experts have stressed that the jab is safe and that there is no evidence linking it to the clots.
The AstraZeneca shot forms the bulk of doses being sent to poorer countries under the WHO-backed Covax scheme, which aims to ensure vaccines reach all parts of the world.
The United States, meanwhile, has ramped up its vaccination programme after a stumbling start, with more than 107 million doses administered in the world's worst-hit nation.
Its top pandemic advisor Anthony Fauci said authorities were considering cutting social distancing rules to three feet (one metre), from the widely accepted six-foot global guideline.
Experts at the US Centers for Disease Control were examining a study that found "no substantial difference" in cases at schools observing six-foot and three-foot separations, Fauci told a CNN show.
New York -- the American city most bereaved by the virus -- marked the one-year anniversary of the pandemic with a tribute Sunday to its 30,258 dead, with candles lit on the famous Brooklyn Bridge.
- 'It's hard for the poor' -
Distancing requirements are a core issue in discussions around the world on reopening schools, with many claiming the six-foot requirement makes it difficult to resume classes without adding portable classrooms or shortening the school day.
Many teachers' unions have also insisted on six-foot distancing.
Remote learning through the internet has been one option, but it has proved difficult to implement in less wealthy nations where many families do not have internet access or devices such as computers, smartphones and tablets.
"The rich have everything they need," said Maria Fe Morallos, a 10th-grade student in the Philippines who cannot afford a smartphone.
"It's hard for the poor because we don't have a gadget or the money to buy it."